IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company sees the business reaching $100mn
The company is making its entry into the Hyderabad market through its unique asset-light business model
H1 FY23 revenues at Rs. 860.1 crore, higher by 40% YoY whereas PAT at Rs. 52.6 crore, higher by 4% YoY
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
A well researched and affordable fixed dose combination, which will significantly improve the glycemic control in adult patients suffering from uncontrolled Type 2 diabetes, especially the ones with comorbidities
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Government Ayurveda College & Hospital will include an infrastructure for the College and a 100 bedded hospital, hostel block for students and staff quarters.
Subscribe To Our Newsletter & Stay Updated